undamentalytics Newsletter
Sign in

Rallybio Corp balance sheet

At the end of fiscal 2025, Rallybio Corp had total assets of $62.3m, total liabilities of $4.3m and shareholders' equity of $58.0m. It held $31.4m in cash against $0 of debt: net cash of $31.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents143191
Total current assets686195
Total assets686296
Accounts payable000
Deferred revenue (current)100
Total current liabilities643
Total debt000
Total liabilities643
Shareholders' equity625892
Net debt (negative = net cash)−14−31−91
Shares outstanding5m5m5m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CRDF vs RLYBCRVO vs RLYBMNOV vs RLYB

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Rallybio Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rallybio Corp.